![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Changes in Intrahepatic, Endogenous Interferon Expression in Chronic HCV, Genotype-1 Patients Treated with Interferon-free, Ribavirin-Free DAA Regimens
|
|
|
Reported by Jules Levin
NY AASLD/EASL Special Conference Sept 2014
Eric G. Meissner1,2, Anita Kohli1,3, Amy Nelson1, Zayani Sims4, John McHutchison5, Henry Masur4, Shyam Kottilil1,6.
1. Laboratory of Immunoregulation/NIAID/NIH, Bethesda, MD.
2. Division of Infectious Diseases, Medical University of South Carolina, Charleston, SC.
3. Clinical Research Directorate/CMRP, SAIC-Frederick, Inc., Frederick, MD.
4. Critical Care Medicine Department/NIH, Bethesda, MD.
5. Gilead Sciences, Foster City, CA.
6. Institute of Human Virology, University of Maryland Medical School, Baltimore, MD.
![AASLD1.gif](../images/112014/112014-4/AASLD1.gif)
![AASLD2.gif](../images/112014/112014-4/AASLD2.gif)
![AASLD3.gif](../images/112014/112014-4/AASLD3.gif)
![AASLD4.gif](../images/112014/112014-4/AASLD4.gif)
![AASLD5.gif](../images/112014/112014-4/AASLD5.gif)
![AASLD6.gif](../images/112014/112014-4/AASLD6.gif)
![AASLD7.gif](../images/112014/112014-4/AASLD7.gif)
![AASLD8.gif](../images/112014/112014-4/AASLD8.gif)
![AASLD9.gif](../images/112014/112014-4/AASLD9.gif)
![AASLD10.gif](../images/112014/112014-4/AASLD10.gif)
![AASLD11.gif](../images/112014/112014-4/AASLD11.gif)
![AASLD12.gif](../images/112014/112014-4/AASLD12.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|